Brilique

Medicinal product

(Invented) name

Brilique

Active substance (s)

Tikagreloras

Strength

90 mg

Pharmaceutical form

burnoje disperguojamos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B01AC24, Ticagrelor

Marketing authorisation holder

AstraZeneca AB, Švedija

Date of authorisation

2010-12-03

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Orodispersible tablet	1 vnt.
Tikagreloras	90 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
68574	83154	1083154	dalomoji lizdinė plokštelė	N10x1		Receptinis	EU/1/10/655/012	Netiekiama	-	-	No	-	-
68575	83155	1083155	dalomoji lizdinė plokštelė	N56x1		Receptinis	EU/1/10/655/013	Netiekiama	-	-	No	-	-
68576	83156	1083156	dalomoji lizdinė plokštelė	N60x1		Receptinis	EU/1/10/655/014	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2010-12-03	Registruotas